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The Role of  STAT3 in Alzheimer’s Disease 
Associated Amyloid Beta Damages
Molly Lawrence
Mentor: Itender Singh
One of the hallmarks of Alzheimer’s disease (AD) is the buildup of amyloid-beta peptide 
in brain parenchyma and blood vessels. Accumulation of these deposits on blood vessels, 
known as cerebral amyloid angiopathy (CAA), has been shown to decrease functional 
reactivity and cerebral blood flow in brain, resulting in cerebrovascular dysfunction and 
cognitive decline.
Amyloid-beta is also found to cause vascular oxidative stress, suggesting that the 
toxicity of the protein is related to the production of reactive oxygen species (ROS). 
Recent studies support this, showing that inhibition of ROS and NADPH oxidase, a 
transmembrane enzyme that catalyzes production of superoxides, reduces amyloid-beta 
related deficits in mice. However, the mechanism by which amyloid-beta causes this 
oxidative stress is not yet well understood.
STAT3 (signal transducer and activator of transcription 3) is known to be a primary 
regulator of NADPH oxidase and is shown to be activated in higher levels in brains 
of Alzheimer’s patients. We hypothesize that STAT3 is a pivotal upstream regulator of 
amyloid-beta induced damage.
Our objective for this study was to evaluate the role of STAT3 in behavioral deficits 
in vivo. We used mice bred to express 5 mutations of familial AD, called the 5xFAD 
model, that are prone to significant amyloid-beta deficits. To inhibit STAT3, 12-month 
old 5xFAD mice showing CAA were injected with an inhibitor drug, LLL-12, over several 
weeks. Subsequently, cognitive function was analyzed through novel object location and 
recognition tests, burrowing behavior tests, and Y-maze tests. We observed improved 
hippocampal dependent memory in the STAT3 inhibited 5xFAD mice compared to their 
littermate controls. This suggests that STAT3 plays a key role in amyloid-beta deficits, 
and could act as an effective therapeutic target for AD patients.
